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Case report
A 38 years-old woman, gravida 2, para 1 came to the
Artemisia Prenatal Diagnosis Centre at 36 weeks of
gestation referred from another institution for the evalu-
ation of a fetal mass in the upper-right abdomen. Previ-
ous ultrasound scanning performed at 18 and at 22
weeks of gestation were negative for fetal abdominal
masses. Amniocentesis performed at 18 weeks of ges-
tation was negative and the alfa fetoprotein in the amni-
otic fluid was 11243 (n.v. < 26000).
The ultrasound scan of the fetus demonstrated a multi-
cystic, well-encapsulated mass in the liver of 7×5×5 cm
in size (Fig.s 1, 2). No calcifications were observed into
the mass; there were both echolucency and echodense
areas. The Doppler flow investigation of the mass
demonstrated a relatively low-absent vascularisation.
Others organ near the neoplasm were all normal. No hy-
drops was observed. The only remarkable sign was the
elevated amniotic fluid index (75° centile). After a multi-
disciplinary counselling a caesarean section was
planned at 37 weeks-of gestation and a strict control of
the fetus with US was performed until the delivery date.
Controls were all negative and polyhydramnios was
equal in all measures. 
The CS was performed at 35 weeks of gestation due to
uterine contractions, giving birth to a 2.9 kg female in-
fant. Apgar scores were 7 and 8 at 1 and 5 minutes re-
spectively. At birth, the abdomen was extremely distend-
ed and the baby was referred to the Bambino Gesù Chil-
dren’s Hospital that is a tertiary care centre with the di-
agnosis of acute abdomen. At physical examination on
arrival the abdomen was distended and tender. An ab-
dominal X-ray showed an elevated diaphragm and virtu-
ally no gas in the bowel. Blood tests were unremarkable.
On the hypothesis of a neonatal volvolus secondary to
an intestinal atresia an emergency laparotomy was car-
ried out. At surgery, a huge mass was found taking up to
three quarters of the abdomen, with the bowel com-
pressed but not necrotic. The mass originated from the
anterior margin of the liver and was pedunculated. The
peduncle was suture ligated and the mass resected. Im-
mediately after the removal of the mass, acute anaemia
occurred (Haemoglobin level 5 g/dl), probably from
blood sequestration into the mass itself, leading to pro-
found bradycardia and cardiac arrest, successfully treat-
ed with prompt cardiopulmonary resususcitation and
blood transfusion. At final histology, the mass was com-
patible with a mesenchimal amartoma of the liver. Post-
operative course was complicated by chylothorax which
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required total parenteral nutrition for two weeks and Oc-
treotide for 7 days, and when enteral nutrition was re-
sumed, a medium chain triglicerides milk was initially
used to reduce the risk of recurrent chylothorax. During
the post-operative course, neurological evaluation and
serial head US were performed which showed no hy-
poxic brain damage, other mutations causing cystic fi-
brosis were excluded by specific genetic testing, and the
girl was discharged on post-operative day 33 in good
clinical. 
Discussion
The incidence of liver masses in general represent ap-
proximately 5% of all congenital tumors (1) and they can
arise from the mesenchymal or endodermal tissues giv-
ing a wide variety of both benign and malignant masses. 
A mesenchymal hamartoma of the liver is the second tu-
mor of the hepatic tissue after the hemangioblastoma
(2) and is a benign neoplasm composed of large, fluid-
filled cyst surrounded by mesenchymal membranes
containing small bile ducts (3), with a rapidly growly
mass.
As most of these tumors are detected in the first year of
life (4) and only 15 % in the neonatal period (5) diagno-
sis “in-utero” is very rare and the differential diagnosis is
very difficult to do because the natural history of the tu-
mor is still not know. Thus only pathological findings af-
ter surgical resection is the cornerstone in the definition
of the mass. 
In this group of fetuses issuing concern the diagnosis
early in pregnancy is of utmost importance due to the
possibility of organs failure related to the growing of the
mass (Hirata et al.) leading to fetal demise (6-8). 
The differential diagnosis of MHL with other abdominal
masses poses challenging problems to the obstetrics
because many malformation both of fetal urinary system
(multicystic renal malformations) and gastrointestinal
tract (congenital atresias and stenosis) could be ex-
changed for a MHL (9). Moreover, no laboratory tests for
liver function are helpful in the early diagnosis of the
MHL (10) and AFP arising in the maternal blood could
be normal the amniotic fluid (11).
Others fetal conditions must be considered in the differ-
ential diagnosis after these discussed above. This in-
cludes bowel obstructions subsequently to a mechoni-
um ileum or neurological disease (9). A good visualiza-
tion of the gastrointestinal system can minimize the er-
ror in the diagnosis. 
Due to the rarity of this condition the management can-
not rely on robust and evidence-based data. We man-
aged our case expectantly in the prenatal period with
serial ultrasound examinations given the lack of compli-
cations
Today is widely accepted the benign nature of the MHL
and the primary endpoint is to reduce the size of the
mass (12). Hence the early diagnosis of abdominal
masses is important because they have the potential to
cause complications such as intestinal ischemia by their
mass effect infect among 6 cases before 31 wks of ges-
tation only 2 were alive and 1 of these had cyst aspira-
tion at 27 (13). Although they may displace adjacent
structures, obstruction of the bowel, vessels, or ureters
is never been described. In general, large cystic mass-
es require surgical excision and when the diagnosis of
MHL is near to term the prognosis seems to be better
and the postnatal surgical treatment is recommended
(14). 
We believe that an early antenatal diagnosis and suc-
cessive follow-up could help to established the time for
delivery making the expectant management an opportu-
nity for this condition.
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